Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Global X Genomics & Biotechnology ETF (NQ:GNOM)

37.67 +0.59 (+1.59%)
Streaming Delayed Price Updated: 2:05 PM EDT, Sep 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,247
Open 37.33
Bid (Size) 37.79 (1)
Ask (Size) 37.92 (4)
Prev. Close 37.08
Today's Range 37.24 - 37.80
52wk Range 6.800 - 37.44
Shares Outstanding 33,418,720
Dividend Yield 0.02%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Qiagen Shares Rise Premarket As Preliminary Q1 Results, Hikes FY25 EPS Guidance
Qiagen (QGEN) shares up premarket after disclosing strong preliminary Q1 2025 results and raising full-year EPS outlook. Stock price up 3.06%. 
Via Benzinga
3 Gene Editing Stocks with Potential to Transform Medicine
Gene-editing holds substantial promise for treating thousands of diseases – creating incredible opportunities for gene editing stocks. 
Via InvestorPlace

Performance

YTD
+284.2%
+284.2%
1 Month
+330.5%
+330.5%
3 Month
+364.4%
+364.4%
6 Month
+315.5%
+315.5%
1 Year
+243.4%
+243.4%

More News

Read More
The 3 Best Gene Editing Stocks to Buy in July 2024
Via InvestorPlace
Genomics Game-Changers: 3 Stocks Unlocking the Secrets of Life
Via InvestorPlace
3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire
Via InvestorPlace
ETF Battles ARKG Vs. GNOM - What's The Better Genomic/Biotech Play?
Via Talk Markets
3 Stocks That Could Be the Next Big Thing in Gene Editing
Via InvestorPlace
3 Gene Editing Stocks With Unprecedented Surge Potential
Via InvestorPlace
3 Once-in-a-Lifetime Gene Editing Stocks with Unprecedented Surge Potential
Via InvestorPlace
3 Gene Editing Stocks to Generate Super-Charged Gains
Via InvestorPlace
The 3 Best CRISPR Stocks to Buy Now Before They Skyrocket
Via InvestorPlace
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector
Via InvestorPlace
3 Gene Editing Stocks With the Best Long-Term Potential
Via InvestorPlace
3 CRISPR Stocks That Will Make You Filthy Rich in 10 Years
Via InvestorPlace
ETF Battles: Finding the Top Genomics Biotech ETF – A Triple Header of ARKG vs IDNA vs GNOM
Via Talk Markets
A Comprehensive Guide To Genomic ETFs
Via Talk Markets
Top-Performing Biotech ETFs of Last Week
Via Talk Markets

Frequently Asked Questions

Is Global X Genomics & Biotechnology ETF publicly traded?
Yes, Global X Genomics & Biotechnology ETF is publicly traded.
What exchange does Global X Genomics & Biotechnology ETF trade on?
Global X Genomics & Biotechnology ETF trades on the Nasdaq Stock Market
What is the ticker symbol for Global X Genomics & Biotechnology ETF?
The ticker symbol for Global X Genomics & Biotechnology ETF is GNOM on the Nasdaq Stock Market
What is the current price of Global X Genomics & Biotechnology ETF?
The current price of Global X Genomics & Biotechnology ETF is 37.67
When was Global X Genomics & Biotechnology ETF last traded?
The last trade of Global X Genomics & Biotechnology ETF was at 09/05/25 02:05 PM ET
What is the market capitalization of Global X Genomics & Biotechnology ETF?
The market capitalization of Global X Genomics & Biotechnology ETF is 1.26B
How many shares of Global X Genomics & Biotechnology ETF are outstanding?
Global X Genomics & Biotechnology ETF has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.